Levocabastine EP Impurity L - Request Quote
Levocabastine EP Impurity L
| SZ CAT No: | SZ-L072013 |
| CAS No | NA |
| Mol.F. | C26H29FN2O3 |
| Mol.Wt. | 436.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Levocabastine EP Impurity L is chemically (3S,4R)-1-[Cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid 1-oxide (as per EP). Levocabastine EP Impurity L is supplied with detailed characterization data compliant with regulatory guideline. Levocabastine EP Impurity L can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Levocabastine Hydrochloride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Levocabastine EP Impurity L
Purchase Levocabastine EP Impurity L
Levocabastine EP Impurity L suppliers
Levocabastine EP Impurity L manufacturers
Levocabastine EP Impurity L price
Order Levocabastine EP Impurity L
Enquire Levocabastine EP Impurity L
Levocabastine EP Impurity L cost
Levocabastine EP Impurity L Supplier
Levocabastine EP Impurity L Distributor
Levocabastine EP Impurity L for Method Validation
Levocabastine Hydrochloride Reference Standard
Levocabastine EP Impurity L for ANDA Filing
Levocabastine EP Impurity L for Forced Degradation Studies
Levocabastine EP Impurity L Identification Standards
Levocabastine EP Impurity L for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.